Lance C. Johnson

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

Maria Bartholomew, Robert W. Jansen, Lennox J. Jeffers et al. · The Lancet · 1997 · 446 citations · Full text

Application of Phosphoramidate Pronucleotide Technology to Abacavir Leads to a Significant Enhancement of Antiviral Potency

Christopher McGuigan, Sarah Harris, Susan M. Daluge et al. · Journal of Medicinal Chemistry · 2005 · 94 citations

Antiviral Potency, Medicinal Chemistry, Abacavir Leads +15

Application of Phosphoramidate ProTide Technology Significantly Improves Antiviral Potency of Carbocyclic Adenosine Derivatives

Christopher McGuigan, Alshaimaa Hassan-Abdallah, Sheila Srinivasan et al. · Journal of Medicinal Chemistry · 2006 · 58 citations

Carbocyclic Adenosine Derivatives, Pharmacotherapy, Antiviral Drug +16

High-capacity in vitro assessment of anti-hepatitis B virus compound selectivity by a virion-specific polymerase chain reaction assay

Robert W. Jansen, Lance C. Johnson, D R Averett · Antimicrobial Agents and Chemotherapy · 1993 · 46 citations

Hepatology, Anti-hbv Compounds, Viral Hepatitis +14

Kinetic Analysis of Wild-Type and YMDD Mutant Hepatitis B Virus Polymerases and Effects of Deoxyribonucleotide Concentrations on Polymerase Activity

Richard Gaillard, Jennifer Barnard, Vincent Lopez et al. · Antimicrobial Agents and Chemotherapy · 2002 · 43 citations · Full text